Search research articles
Contact Us
Filters
Showing results (1301-1310 of 1,340) with videos related to
Page
of 134
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 9, 2016
A Phase I/II Multicenter Study of Single-Agent Foretinib as First-Line Therapy in Patients with Advanced Hepatocellular Carcinoma
Thomas C C Yau, Riccardo Lencioni, Wattana Sukeepaisarnjaroen, et al.
Journal of Neuroinflammation
|
March 18, 2018
Therapeutic time window of multipotent adult progenitor therapy after traumatic brain injury
Supinder S Bedi, Benjamin M Aertker, George P Liao, et al.
Plos One
|
October 14, 2009
Genomic diversity among drug sensitive and multidrug resistant isolates of Mycobacterium tuberculosis with identical DNA fingerprints
Stefan Niemann, Claudio U Köser, Sebastien Gagneux, et al.
Annals of the American Thoracic Society
|
September 23, 2024
Telerehabilitation Compared to Center-based Pulmonary Rehabilitation for People with Chronic Respiratory Disease: Economic Analysis of a Randomized, Controlled Clinical Trial
Angela T Burge, Narelle S Cox, Anne E Holland, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
November 24, 2016
A Phase 1/1b Study Evaluating Trametinib Plus Docetaxel or Pemetrexed in Patients With Advanced Non-Small Cell Lung Cancer
David R Gandara, Natasha Leighl, Jean-Pierre Delord, et al.
The Lancet. Oncology
|
July 19, 2012
Safety, pharmacokinetic, pharmacodynamic, and efficacy data for the oral MEK inhibitor trametinib: a phase 1 dose-escalation trial
Jeffrey R Infante, Leslie A Fecher, Gerald S Falchook, et al.
Stem Cells (Dayton, Ohio)
|
September 19, 2019
Intravenous Bone Marrow Mononuclear Cells for Acute Ischemic Stroke: Safety, Feasibility, and Effect Size from a Phase I Clinical Trial
Farhaan S Vahidy, Muhammad E Haque, Mohammad H Rahbar, et al.
Annals of Neurology
|
November 14, 2025
Polygenic Vulnerability to Intracranial Hypertension, Hemorrhage Progression, and Outcome in Traumatic Brain Injury
Margaux E Miller, Benjamin E Zusman, Chia-Ling Phuah, et al.
Plos One
|
October 8, 2011
Bone marrow derived mesenchymal stem cells inhibit inflammation and preserve vascular endothelial integrity in the lungs after hemorrhagic shock
Shibani Pati, Michael H Gerber, Tyler D Menge, et al.
Stem Cells (Dayton, Ohio)
|
November 2, 2016
Treatment of Severe Adult Traumatic Brain Injury Using Bone Marrow Mononuclear Cells
Charles S Cox, Robert A Hetz, George P Liao, et al.
Page
of 134
Search research articles
Search
Showing results (1301-1310 of 1,340) with videos related to
Sort By:
Page
of 134
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 9, 2016
A Phase I/II Multicenter Study of Single-Agent Foretinib as First-Line Therapy in Patients with Advanced Hepatocellular Carcinoma
Thomas C C Yau, Riccardo Lencioni, Wattana Sukeepaisarnjaroen, et al.
Journal of Neuroinflammation
|
March 18, 2018
Therapeutic time window of multipotent adult progenitor therapy after traumatic brain injury
Supinder S Bedi, Benjamin M Aertker, George P Liao, et al.
Plos One
|
October 14, 2009
Genomic diversity among drug sensitive and multidrug resistant isolates of Mycobacterium tuberculosis with identical DNA fingerprints
Stefan Niemann, Claudio U Köser, Sebastien Gagneux, et al.
Annals of the American Thoracic Society
|
September 23, 2024
Telerehabilitation Compared to Center-based Pulmonary Rehabilitation for People with Chronic Respiratory Disease: Economic Analysis of a Randomized, Controlled Clinical Trial
Angela T Burge, Narelle S Cox, Anne E Holland, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
November 24, 2016
A Phase 1/1b Study Evaluating Trametinib Plus Docetaxel or Pemetrexed in Patients With Advanced Non-Small Cell Lung Cancer
David R Gandara, Natasha Leighl, Jean-Pierre Delord, et al.
The Lancet. Oncology
|
July 19, 2012
Safety, pharmacokinetic, pharmacodynamic, and efficacy data for the oral MEK inhibitor trametinib: a phase 1 dose-escalation trial
Jeffrey R Infante, Leslie A Fecher, Gerald S Falchook, et al.
Stem Cells (Dayton, Ohio)
|
September 19, 2019
Intravenous Bone Marrow Mononuclear Cells for Acute Ischemic Stroke: Safety, Feasibility, and Effect Size from a Phase I Clinical Trial
Farhaan S Vahidy, Muhammad E Haque, Mohammad H Rahbar, et al.
Annals of Neurology
|
November 14, 2025
Polygenic Vulnerability to Intracranial Hypertension, Hemorrhage Progression, and Outcome in Traumatic Brain Injury
Margaux E Miller, Benjamin E Zusman, Chia-Ling Phuah, et al.
Plos One
|
October 8, 2011
Bone marrow derived mesenchymal stem cells inhibit inflammation and preserve vascular endothelial integrity in the lungs after hemorrhagic shock
Shibani Pati, Michael H Gerber, Tyler D Menge, et al.
Stem Cells (Dayton, Ohio)
|
November 2, 2016
Treatment of Severe Adult Traumatic Brain Injury Using Bone Marrow Mononuclear Cells
Charles S Cox, Robert A Hetz, George P Liao, et al.
Page
of 134